no statement of use filed
on 17 Jul 2023
Last Applicant/ Owned by
400 Interpace Parkway
Parsippany
NJ
07054
Serial Number
88728511 filed on 16th Dec 2019
Registration Number
N/A
Correspondent Address
Teva Pharmaceuticals USA, Inc.
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and tRead More
Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of neurological disorders
No 88728511
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
17th Jul 2023 | ABANONMENT - NO USE STATEMENT ILE |
17th Jul 2023 | ABANONMENT NOTICE E-MAILE - NO USE STATEMENT ILE |
05th Jan 2023 | NOTICE O APPROVAL O EXTENSION REQUEST E-MAILE |
04th Jan 2023 | CASE ASSIGNE TO INTENT TO USE PARALEGAL |
04th Jan 2023 | SOU EXTENSION 5 GRANTE |
14th Dec 2022 | SOU TEAS EXTENSION RECEIVE |
14th Dec 2022 | SOU EXTENSION 5 ILE |
17th Jun 2022 | NOTICE O APPROVAL O EXTENSION REQUEST E-MAILE |
15th Jun 2022 | SOU TEAS EXTENSION RECEIVE |
15th Jun 2022 | SOU EXTENSION 4 ILE |